Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TELMISARTAN | 40MG | TABLET | Resolved | 2020-07-08 | 2020-10-21 | 119744 |
| TELMISARTAN | 40MG | TABLET | Actual shortage | 2024-03-25 | 2024-04-15 | 223276 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-02-12 | 2021-08-04 | 105868 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-09 | 217837 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-02-26 | 2024-05-01 | 220681 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-14 | 2018-10-31 | 58053 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-07 | 2019-05-28 | 71379 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| OLMESARTAN | 40MG | TABLET | Actual shortage | 2024-03-11 | 2024-03-11 | 221872 |
| MONTELUKAST | 4MG | TABLET (CHEWABLE) | Actual shortage | 2019-02-19 | 2019-04-20 | 76272 |
| MONTELUKAST | 4MG | TABLET (CHEWABLE) | Actual shortage | 2019-04-18 | 2019-04-19 | 81981 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-06-14 | 2017-06-22 | 12745 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2018-09-07 | 2018-11-22 | 60200 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96874 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2020-02-27 | 2020-03-27 | 107296 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |